Prevalence of p21 immunohistochemical expression in esophageal adenocarcinoma Prevalência da expressão imunoistoquímica da proteína p21 em adenocarcinoma do esôfago

Prevalence of p21 immunohistochemical expression in esophageal adenocarcinoma Prevalência da expressão imunoistoquímica da proteína p21 em adenocarcinoma do esôfago

BACKGROUND: In western societies, the prevalence of adenocarcinoma of the gastroesophageal junction has increased in recent years. It is commonly accepted today that esophageal adenocarcinoma develops from a premalignant lesion: Barrett's esophagus. This type of carcinoma is hardly diagnosed at...

Full description

Bibliographic Details
Main Authors: Maitê de Mello Villwock, Luise Meurer, Leandro Totti Cavazzola, Richard R. Gurski, Maria Isabel Edelweiss, Carlos Cauduro Schirmer
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2006-09-01
Series:Arquivos de Gastroenterologia
Subjects:
Neoplasia esofágicas
Adenocarcinoma
Inibidor de quinase depedendente de ciclina p21
Esophageal neoplasms
Cyclin-dependent kinase inhibitor p21
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032006000300011

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032006000300011

Similar Items